Vaksin Arexvy GSK untuk RSV diluluskan di Malaysia
GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) hari ini mengumumkan bahawa vaksin Arexvy (MAL24086007ARZ) telah diluluskan di Malaysia untuk virus sinsitium pernafasan (RSV).
Tue Sep 24 2024
GSK Malaysia tarik balik satu kumpulan Zyrtec-D
Keputusan menarik balik produk itu adalah langkah berjaga-jaga selepas sebahagian unit ditemukan mempunyai kerosakan dan tidak dipek dengan betul.
Thu Mar 30 2023
Vaksin malaria pertama dunia akan beri manfaat kepada berjuta kanak-kanak - UNICEF
Pada 2020, hampir setengah juta kanak-kanak lelaki dan perempuan mati akibat penyakit itu di Afrika sahaja, pada kadar satu kematian setiap minit.
Wed Aug 17 2022
World's first malaria vaccine to benefit millions of children: UNICEF
The landmark award, valued at up to US$170 million, will lead to 18 million doses of the RTS,S vaccine available over the next three years.
Wed Aug 17 2022
What you need to know about the coronavirus right now
China said will fully support Hong Kong with its "dynamic zero" coronavirus strategy.
Fri Feb 11 2022
Ubat COVID-19: EU tandatangan perjanjian dengan GSK
Dibangunkan bersama firma Amerika Syarikat Vir Biotechnology, ubat ini boleh digunakan untuk pesakit koronavirus berisiko tinggi dengan gejala ringan, yang tidak memerlukan oksigen.
Wed Jul 28 2021
U.S. FDA gives emergency use approval for GSK-Vir COVID-19 antibody drug
Sotrovimab, is not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy.
Wed May 26 2021
Vir, GSK's COVID-19 antibody trial shows 85 pct drop in hospitalization or death
They were planning to submit an emergency use authorization application to the U.S. Food and Drug Administration for the treatment.
Thu Mar 11 2021
GSK, CureVac team up to develop vaccine against COVID-19 variants
A CureVac spokesman said that would firm up the group's target to produce up to 300 million doses this year.
Wed Feb 03 2021
Sanofi and GSK delay COVID-19 vaccine, marking setback for global fight
Sanofi and GlaxoSmithKline said clinical trials of their COVID-19 vaccine showed an insufficient immune response in older people, delaying its launch to late next year.
Fri Dec 11 2020
China's Clover says its COVID-19 vaccines trigger "strong immune responses" in early trial
Based on positive Phase 1 results reported, Clover is confident to enter late-stage clinical development for both adjuvanted vaccines.
Fri Dec 04 2020
US Operation Warp Speed backed vaccines for whole world
The president described the effort as "a massive scientific, industrial and logistical endeavour unlike anything our country has seen since the Manhattan Project,"
Sat Nov 28 2020
Adman Paul Arnold: You Can't Get Away With Lies
Advertising and brand specialist Paul Arnold was in town, just in time to witness the aftermath of GE14. He comes away with ammunition that truth and transparency in brand messaging.
Thu Jul 12 2018
Experimental Ebola vaccine doses ready by 2015: WHO
Thousands of experimental Ebola vaccine doses from British GSK and US NewLink should be ready for use by early 2015, the WHO said.
Fri Sep 26 2014
China bars GSK executive from leaving amid bribery probe
Chinese authorities have barred the British finance director of GlaxoSmithKline (GSK) in China from leaving the country.
Thu Jul 18 2013